Literature DB >> 9584118

Eyeless initiates the expression of both sine oculis and eyes absent during Drosophila compound eye development.

G Halder1, P Callaerts, S Flister, U Walldorf, U Kloter, W J Gehring.   

Abstract

The Drosophila Pax-6 gene eyeless acts high up in the genetic hierarchy involved in compound eye development and can direct the formation of extra eyes in ectopic locations. Here we identify sine oculis and eyes absent as two mediators of the eye-inducing activity of eyeless. We show that eyeless induces and requires the expression of both genes independently during extra eye development. During normal eye development, eyeless is expressed earlier than and is required for the expression of sine oculis and eyes absent, but not vice versa. Based on the results presented here and those of others, we propose a model in which eyeless induces the initial expression of both sine oculis and eyes absent in the eye disc. sine oculis and eyes absent then appear to participate in a positive feedback loop that regulates the expression of all three genes. In contrast to the regulatory interactions that occur in the developing eye disc, we also show that in the embryonic head, sine oculis acts in parallel to eyeless and twin of eyeless, a second Pax-6 gene from Drosophila. Recent studies in vertebrate systems indicate that the epistatic relationships among the corresponding vertebrate homologs are very similar to those observed in Drosophila.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9584118     DOI: 10.1242/dev.125.12.2181

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  129 in total

1.  Searching for the prototypic eye genetic network: Sine oculis is essential for eye regeneration in planarians.

Authors:  D Pineda; J Gonzalez; P Callaerts; K Ikeo; W J Gehring; E Salo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Notch signaling and the determination of appendage identity.

Authors:  S Kurata; M J Go; S Artavanis-Tsakonas; W J Gehring
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

3.  Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation.

Authors:  T A Heanue; R Reshef; R J Davis; G Mardon; G Oliver; S Tomarev; A B Lassar; C J Tabin
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

4.  Six3 overexpression initiates the formation of ectopic retina.

Authors:  F Loosli; S Winkler; J Wittbrodt
Journal:  Genes Dev       Date:  1999-03-15       Impact factor: 11.361

5.  Pax6 activity in the lens primordium is required for lens formation and for correct placement of a single retina in the eye.

Authors:  R Ashery-Padan; T Marquardt; X Zhou; P Gruss
Journal:  Genes Dev       Date:  2000-11-01       Impact factor: 11.361

6.  Expression of evolutionarily conserved eye specification genes during Drosophila embryogenesis.

Authors:  J P Kumar; K Moses
Journal:  Dev Genes Evol       Date:  2001-09       Impact factor: 0.900

7.  The eyeless homeodomain is dispensable for eye development in Drosophila.

Authors:  C Punzo; S Kurata; W J Gehring
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

8.  Conservation of Pax 6 function and upstream activation by Notch signaling in eye development of frogs and flies.

Authors:  Yasuko Onuma; Shuji Takahashi; Makoto Asashima; Shoichiro Kurata; Walter J Gehring
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

9.  PAX6 expression in the developing human eye.

Authors:  S Nishina; S Kohsaka; Y Yamaguchi; H Handa; A Kawakami; H Fujisawa; N Azuma
Journal:  Br J Ophthalmol       Date:  1999-06       Impact factor: 4.638

10.  Expression and function of scalloped during Drosophila development.

Authors:  Kirsten A Guss; Michael Benson; Nicholas Gubitosi; Karrie Brondell; Kendal Broadie; James B Skeath
Journal:  Dev Dyn       Date:  2013-06-03       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.